Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Por tema
Enfermedad de Parkinson
3833 ARTíCULOS , VIENDO DEL 2431 AL 2445
The thermodynamic hypothesis of protein aggregation
Vendruscolo M.
Mol Aspects Med. 2025 Jun;103:101364. doi: 10.1016/j.mam.2025.101364. Epub 2025 May 3.
0
0
0
The multifaceted roles of Akkermansia muciniphila in neurological disorders
Ma X, Liu Q, Yang G.
Trends Neurosci. 2025 Jun;48(6):403-415. doi: 10.1016/j.tins.2025.04.004. Epub 2025 May 6.
0
0
0
α-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease
Mingo YB, Escobar Galvis ML, Henderson MX.
Neurobiol Dis. 2025 Jun 1;209:106889. doi: 10.1016/j.nbd.2025.106889. Epub 2025 Mar 27.
0
0
0
Leucine-rich repeat kinase 2 biomarkers for Parkinson's disease
Dzamko N.
Biochem J. 2025 May 28;482(11):709-20. doi: 10.1042/BCJ20253099.
0
0
0
CBT for psychosis in Parkinson's disease: A framework for how and why
Foley JA, Bell V.
Schizophr Res. 2025 Jun;280:69-75. doi: 10.1016/j.schres.2025.04.023. Epub 2025 Apr 19.
0
0
0
Mini Review: Spatial Transcriptomics to Decode the Central Nervous System
Pesti B, Langa X, Kumpesa N, Valdeolivas A, Sultan M, Rottenberg S, Hahn K.
Toxicol Pathol. 2025 Jun;53(4):397-402. doi: 10.1177/01926233251325204. Epub 2025 Mar 22.
0
0
0
Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson's Disease
Blair HA.
CNS Drugs. 2025 Jun;39(6):621-632. doi: 10.1007/s40263-025-01179-3. Epub 2025 Apr 8.
0
0
0
Stem cell therapy for Parkinson's disease: A new hope for neural regeneration
Mokhtari YG, Varnava I, Kyrgiannis K, Ampatsidou V, Giakoumettis D.
World J Biol Chem. 2025 Jun 5;16(2):106850. doi: 10.4331/wjbc.v16.i2.106850.
0
0
0
Bacanoiu MV, Rusu L, Marin MI, Piele D, Rusu MR, Danoiu R, Danoiu M.
J Clin Med. 2025 Jun 11;14(12):4140. doi: 10.3390/jcm14124140.
0
0
0
Reply to: "Chronic Pain and Parkinson's Disease: Causation or Confounding?"
Vazirian F, Tian J, Cicuttini F, Jones G, Pan F.
Mov Disord. 2025 Jun;40(6):1220. doi: 10.1002/mds.30234. Epub 2025 May 23.
0
0
0
Is SIRT3 and Mitochondria a Reliable Target for Parkinson's Disease and Aging? A Narrative Review
Kandy AT, Chand J, Baba MZ, Subramanian G.
Mol Neurobiol. 2025 Jun;62(6):6898-6912. doi: 10.1007/s12035-024-04486-w. Epub 2024 Sep 17.
0
0
0
Cell biological insights into human STING variants
Koide S, Yumoto E, Nakayama J, Higashiyama S, Kuchitsu Y, Taguchi T.
Cell Struct Funct. 2025 Jun 7;50(1):135-144. doi: 10.1247/csf.25020. Epub 2025 May 14.
0
0
0
Gut neuropeptide involvement in Parkinson's disease
Templeton HN, Tobet SA, Schwerdtfeger LA.
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G716-G733. doi: 10.1152/ajpgi.00383.2024. Epub 2025 Apr 25.
0
0
0
Dravet syndrome: From neurodevelopmental to neurodegenerative disease?
Selvarajah A, Sabo A, Gorodetsky C, Marques PT, Chandran I, Thompson M, Zulfiqar Ali Q, McAndrews MP, Tartaglia MC, Lira VST, Huh L, Connolly M, Rezazadeh A, Qaiser F, Fantaneanu TA, Duong M, Barboza
Epilepsia. 2025 Jun;66(6):1975-1987. doi: 10.1111/epi.18329. Epub 2025 Mar 4.
0
0
0
The Role of Kinases in Neurodegenerative Diseases: From Pathogenesis to Treatment
Naim A, Farooqui AM, Badruddeen, Khan MI, Akhtar J, Ahmad A, Islam A.
Eur J Neurosci. 2025 Jun;61(11):e70156. doi: 10.1111/ejn.70156.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
